Stockreport

Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities [Yahoo! Finance]

NORTHWEST BIOTHRPUTCS INC  (NWBO) 
US:NASDAQ Investor Relations: nwbio.com/investors-media
PDF July 3, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor [Read more]